ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0488

Discrepancies in Temporal Artery Biopsy Positivity Rate Among White and Black Patients Suspected of Having Giant Cell Arteritis: Experience from a Tertiary Academic Medical Center

Raj Vachhani1, Peng Li2, Mehdi Tavakoli2, Lanning Kline2 and Angelo Gaffo2, 1University of Alabama at Birmingham, Homewood, AL, 2University of Alabama at Birmingham, Birmingham, AL

Meeting: ACR Convergence 2022

Keywords: giant cell arteritis, race/ethnicity, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Vasculitis – Non-ANCA-Associated and Related Disorders Poster I: Giant Cell Arteritis

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: A prior study evaluated incidence rates of biopsy proven giant cell arteritis (GCA) among black and white patients, concluding that GCA occurs at a similar rate in both groups. Our hypothesis, based on clinical experience at our institution, is that GCA is rare among black patients. To evaluate this, we compared the temporal artery biopsy (TAB) positivity rates among our white and black patients.

Methods: We conducted a retrospective chart review from all patients who underwent TAB at our affiliated Eye Hospital from 2012 until 2021. Data extracted included age, sex, race/ethnicity, presence of non-visual symptoms (headache, jaw claudication, facial pain, or constitutional symptoms), visual symptoms (blurred or complete vision loss – bilateral or monocular, history of transient vision loss), and laboratory data (sedimentation rate, C-Reactive Protein). The main study outcome was the rate of positivity in the TAB. Patients with biopsies that were non-diagnostic, but had an abnormal internal elastic lamina were considered negative. Sensitivity analysis were also done considering this group as positive. The main independent variable for our study was race/ethnicity: patients were grouped as general population (all patients), white, and black patients per administrative demographics in the electronic medical record.Clinical and demographic features of patients undergoing TAB were compared between those with positive and negative biopsies with t tests, Wilcoxon rank sum test, Chi-squared test, or Fisher’s exact test where appropriate. A logistic regression was performed with factors found to be significant at p< 0.1 in bivariate analysis to evaluate for independent associations with a positive biopsy, with special attention to race/ethnicity. However, jaw claudication and constitutional symptoms could not be included in logistic regression due to amount of missing data. A p value of < 0.05 was considered statistically significant in this analysis.

Results: Data from 385 patients who had TAB performed for suspected GCA were included (290 white, 95 black). White and black patients had similar demographic and clinical characteristics, otherwise the only difference was higher mean ESR in black patients (Table 1).

Of all patients referred for TAB, 17.4% (65 patients) had a result diagnostic for GCA. Positivity rate in white patients was 20.3% and 8.4% in black patients (Table 2). 33 biopsies (8.6%) were non-diagnostic with only internal elastic lamina disruption (Table 2). Patients with positive TAB were more likely to have jaw claudication, constitutional symptoms and higher inflammatory markers (Table 2). In the logistic regression analysis for factors independently associated with a positive result in TAB, white race compared to black race was associated with a significant odds ratio of 3.47 (95%CI:1.14-10.59, p < 0.03). Another factor associated with a positive biopsy was age, and there was a negative association with blurry vision (Table 3). Sensitivity analysis did not change our results.

Conclusion: Our study supports the hypothesis that there is a discrepancy in the frequency of GCA, in this case through the positivity rate in TAB, between black patients and white patients – with lower rates in the former.

Supporting image 1

Table 1. Clinical and demographic features of patients undergoing temporal artery biopsy for diagnosis if GCA, by race/ethnicity

Supporting image 2

Table 2. Temporal artery biopsy results, stratified by race/ethnicity

Supporting image 3

Table 3. Bivariate analysis and logistic regression for associations with a positive temporal artery biopsy


Disclosures: R. Vachhani, None; P. Li, None; M. Tavakoli, None; L. Kline, None; A. Gaffo, None.

To cite this abstract in AMA style:

Vachhani R, Li P, Tavakoli M, Kline L, Gaffo A. Discrepancies in Temporal Artery Biopsy Positivity Rate Among White and Black Patients Suspected of Having Giant Cell Arteritis: Experience from a Tertiary Academic Medical Center [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/discrepancies-in-temporal-artery-biopsy-positivity-rate-among-white-and-black-patients-suspected-of-having-giant-cell-arteritis-experience-from-a-tertiary-academic-medical-center/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/discrepancies-in-temporal-artery-biopsy-positivity-rate-among-white-and-black-patients-suspected-of-having-giant-cell-arteritis-experience-from-a-tertiary-academic-medical-center/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology